Wikisage, the free encyclopedia of the second generation, is digital heritage
Drisapersen: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
An exon skipping experimental [[drug|Medicine]]<ref>https://web.archive.org/web/20120729012249/http://www.prosensa.eu/technology-and-products/pipeline/pro051gsk2402968</ref> | An exon skipping experimental [[drug|Medicine]]<ref>https://web.archive.org/web/20120729012249/http://www.prosensa.eu/technology-and-products/pipeline/pro051gsk2402968</ref> | ||
<ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref> | <ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref> | ||
PRO051/GSK2402968 is considered an orphan drug | PRO051/GSK2402968 is considered an orphan drug. | ||
Drisapersen | '''Drisapersen''' | ||
differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged <ref>[https://www.dovepress.com/eteplirsen-in-the-treatment-of-duchenne-muscular-dystrophy-peer-reviewed-fulltext-article-DDDT Eteplirsen in the treatment of Duchenne muscular dystrophy]</ref> | differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged <ref>[https://www.dovepress.com/eteplirsen-in-the-treatment-of-duchenne-muscular-dystrophy-peer-reviewed-fulltext-article-DDDT Eteplirsen in the treatment of Duchenne muscular dystrophy]</ref> | ||
[[Duchenne muscular distrophy]] | [[Duchenne muscular distrophy]] |
Revision as of 23:41, 11 September 2019
An exon skipping experimental Medicine[1] [2] PRO051/GSK2402968 is considered an orphan drug. Drisapersen differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged [3] Duchenne muscular distrophy
Links
Duchenne muscular dystrophy: Still an incurable disease
Eteplirsen a 30-nucleotide phosphorodiamidate morpholino oligomer
References: |